Syndicate Market Research

Hematology Diagnostics Market Is Considered as One of the Rapidly Growing Market by 2021

Hematology Diagnostics Market Volume Forecast and Value Chain Analysis 2021


Deerfield Beach, FL -- (SBWIRE) -- 02/09/2017 -- Hematology is a branch of medicine and deals with study, treatment, and prevention of blood diseases. This term refer to study of blood, blood-forming organs, and blood diseases and used in respective treatment. Hematology also deals with the problems associated with white blood cells, red blood cells, bone marrow, lymph, and platelets. Blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology are the different IVD technologies involved in hematology. Hematology helps to cure or in the treatment of bleeding disorders such as hemophila and blood clots, and blood cancer. Hematology helps to recognize anemia, infection, hemophilia, and blood clotting.

Increasing global prevalence of blood related disease is expected to drive the hematology diagnostics market over the forecast period. Increasing adoption of automated hematology devices by diagnostics laboratories and technological advancements is another driving factor of hematology diagnostics market. Some issues like high cost of hematology diagnostic devices may hamper the growth of hematology diagnostics market.

Get Sample Research Report at:

The report provides a comprehensive view on the hematology diagnostics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the hematology diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report.

The report segments the hematology diagnostics market on the basis of product, application and geography. Hematology analyzers and hematology reagents are two major product segments analyzed in this study. On the basis of application segment, hematology diagnostics are segmented into hospitals, clinical laboratories, and academic and research institutes.

Browse the full report at:

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the country level, which include U.S., Germany, UK, France, China, Japan and India. North America dominated the overall industry in terms of revenue in 2014 and followed by Europe due to the availability of a large number of diagnostic centers.

The key players of the hematology diagnostics market include Abbott Laboratories, Hemocue, Horiba, Siemens Healthcare diagnostics, and Beckman Coulter, Abbott Laboratories, Bio-Rad Laboratories, x and Roche Diagnostics.

The report segments the global hematology diagnostics market into:

Global Hematology Diagnostics Market: Product Segment Analysis

Hematology analyzers
Global Hematology Diagnostics Market: Application Segment Analysis

Clinical Laboratories
Academic and Research Institutes
Global Hematology Diagnostics Market: Regional Segment Analysis

North America
Asia Pacific
Latin America
Middle East & Africa

Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803